IRVINE, Calif. - ReShape Lifesciences (NASDAQ:RSLS), a micro-cap company with a market capitalization of $2.69 million specializing in weight loss and metabolic health solutions, has been granted a ...
POMONA, NEW YORK, UNITED STATES, January 31, 2024 /EINPresswire.com/ -- NeuroLight, Inc. today announced the recent grant of US Patent No. 11,413,425 for the ...
ImagineHealth and Vivatronix partner to bring SpineX’s neuromodulation technology to global markets, enhancing recovery for neurological condition patients. Patients have been waiting for a solution ...
The R&D on neuromodulation technology for the treatment and management of metabolic syndrome conducted by a team led by Dr. Ki-young Shin of Human Care Electro-Medical Device Research Center, ...
(BPT) - New precision neuromodulation techniques are redefining what's possible for neurological recovery, and the National Institutes of Health (NIH) has made a substantial investment to support the ...
ReShape Lifesciences® announced the granting of an international patent for its Diabetes Neuromodulation technology from the Australian Patent Office, providing protection until April 12, 2039. This ...
ReShape Lifesciences has received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent application on a new Diabetes Neuromodulation system utilizing its vagal nerve block ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback